Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Sleep Disorders Treatment: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering.
The report covers the market for sleep disorders treatment across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. The report estimates the global market for Sleep Disorder Treatments in 2021 and provides projections for the expected market size through 2027.
As sleep disorders become more common, the demand for sleep problem treatment alternatives will rise. As a result, it is expected that increased mental stress caused by a hectic lifestyle and bad habits will fuel the growth of the market for treating sleep disorders. Because of the seriousness of the negative effects, patients may be afraid to consume medication, lowering demand and sales. Growing technological development is increasing the market's demand for sleep disorder treatments.
Additionally, medications for the treatment of chronic conditions are used over an extended time and have side effects that are thought to impair a patient's ability to sleep. Therefore, the market is growing as chronic diseases like cancer become more common. For instance, The National Institute of Cancer (NIC) found that, in 2021, 1,806,590 cancer cases were identified in the U.S. The adverse effects of cancer chemotherapy on the patient's body affect sleep quality.
In this report, the global market for sleep disorders treatment has been segmented based on product type, medication type, and geography. Based on product type, the sleep disorders treatment market has been categorized into antidepressants, benzodiazepines, nonbenzodiazepines, melatonin antagonists, and others. Based on medication type, the sleep disorders treatment market is categorized into OTC drugs, herbal drugs, and prescription-based drugs. By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The North America region is currently the most dominant market for the sleep disorders treatment market.
Report Includes
- An updated overview and in-depth analysis of the global market for global sleep disorder treatment
- Analyses of the global market trends, with historic market revenue data for 2021, estimates for 2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2027
- Discussion of industry growth driving factors and major technology issues and challenges affecting the market for sleep disorders treatment as a basis for projecting demand over the next few years (2022-2027)
- Estimation of the actual market size and revenue forecast for global sleep disorder treatment market in USD million values, and corresponding market share analysis by product type, drug type, and region
- A comparative study and Porter's Five Forces analysis considering both the micro and macro environmental factors prevailing in the sleep disorder treatment market
- Holistic review of the impact of the COVID-19 pandemic and the Russia-Ukraine war on the global sleep disorders treatment markets
- Coverage of the technological, economic, and business considerations of the global sleep disorder treatment market, with market data analyses and growth forecasts through 2027
- Identification of the major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, and segmental revenues
- Company profiles of major players within the industry, including Jazz Pharmaceuticals plc, Pfizer Inc., Sanofi S.A., and Zydus Cadila Group
Key Topics Covered:
Chapter 1 Market Outlook
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Market Opportunities and Technology Snapshot
4.1 Market Opportunities
4.1.1 Implementation of Artificial Intelligence in Sleep Disorders
4.1.2 Growing Demand for Home Sleep Test
4.2 Regulation of Sleep
4.2.1 Neurotransmitter Regulation
4.2.2 Hypothalamic Regulation
4.2.3 Pharmaceutical Regulation
4.3 Various Distribution Channels
4.3.1 Online Pharmacy
4.3.2 Offline Pharmacy
4.4 Type of Product
4.4.1 Branded
4.4.2 Generic
Chapter 5 Market Breakdown by Drug/Product Type
5.1 Market for Sleep Disorder Treatments by Type of Drug
5.1.1 Benzodiazepines
5.1.2 Nonbenzodiazepines
5.1.3 Antidepressants
5.1.4 Melatonin Antagonists
5.1.5 Others
5.2 Market for Sleep Disorder Treatments by Type of Product
5.2.1 Over-The-Counter (Otc) Drugs
5.2.2 Prescription-Based Drugs
5.2.3 Herbal-Based Drugs
Chapter 6 Market Breakdown by Region
6.1 Overview
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Latin America
6.6 Middle East and Africa
Chapter 7 Company Profiles
Chapter 8 Project Scope and Methodology
Companies Mentioned
- Azurity Pharmaceuticals Inc.
- Hikma Pharmaceuticals plc
- Idorsia Pharmaceuticals Ltd.
- Jazz Pharmaceuticals plc
- Merck & Co. Inc.
- Pfizer Inc.
- Sanofi S.A.
- Vanda Pharmaceuticals
- Viatris Inc.
- Zydus Cadila Group
For more information about this report visit https://www.researchandmarkets.com/r/7s8tk7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
